Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
20 Jun 2016 NICE UK Updates its Quality Standard in Breast Cancer Breast cancer
16 Jun 2016 Adjuvant Combination Therapy Improves Survival in Pancreatic Cancer Gastrointestinal cancers - Anticancer agents & Biologic therapy
14 Jun 2016 NICE UK Issues New Guidance for Cabazitaxel Genitourinary cancers - Anticancer agents & Biologic therapy
13 Jun 2016 EMA Recommends Granting a Marketing Authorisation for Generic Bortezomib Haematologic malignancies - Anticancer agents & Biologic therapy
08 Jun 2016 Immune Modulation in Colorectal and Anal Cancers Gastrointestinal cancers - Cancer Immunology and Immunotherapy
07 Jun 2016 EMA Recommends Extension of Therapeutic Indications for Brentuximab Vedotin Haematologic malignancies - Anticancer agents & Biologic therapy
06 Jun 2016 FDA Approves New Diagnostic Imaging Agent to Detect Rare Neuroendocrine Tumours Imaging - Endocrine cancers
03 Jun 2016 FDA Approves First Blood Test to Detect EGFR mutations associated with NSCLC Personalised medicine - Lung and other thoracic tumours
02 Jun 2016 FDA Approves New Diagnostic Imaging Agent to Detect Recurrent Prostate Cancer Genitourinary cancers - Imaging
01 Jun 2016 All European Scientific Articles to be Freely Accessible by 2020 Bioethics, legal and economic issues
31 May 2016 EMA Recommends to Refuse Marketing Authorisation for Ixazomib Haematologic malignancies - Anticancer agents & Biologic therapy
30 May 2016 Withdrawal of the EU Marketing Authorisation Application for Rociletinib Lung and other thoracic tumours - Anticancer agents & Biologic therapy
24 May 2016 Responsible and Effective Sharing of Cancer Genome Data Personalised medicine
23 May 2016 Unprecedented Progress in the Treatment of NSCLC Lung and other thoracic tumours - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
20 May 2016 FDA Grants Accelerated Approval to Nivolumab for the Treatment of Hodgkin Lymphoma Haematologic malignancies - Cancer Immunology and Immunotherapy